# Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

> **NCT01711983** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 400 (actual)

## Conditions studied

- Septal Defect, Atrial

## Interventions

- **DEVICE:** GORE® CARDIOFORM Septal Occluder

## Key facts

- **NCT ID:** NCT01711983
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2018-11-26
- **Final completion:** 2018-11-26
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2020-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711983, "Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01711983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*